This article provides a brief overview of research with human pluripotent stem cells in Brazil, the federal funding supporting this research, and the legislation that allows the isolation of human embryonic stem cells.
Get full access to this article
View all access options for this article.
References
1.
FragaAM, SukoyanM, RajanP, BragaDP, IaconelliA, FrancoJG, BorgesE and PereiraLV. (2011). Establishment of a Brazilian line of human embryonic stem cells in defined medium: implications for cell therapy in an ethnically diverse population. Cell Transplant, 20:431–440.
2.
MarinhoPA, VareschiniDT, GomesIC, PaulsenBaS, FurtadoDR, CastilhoLoR and RehenSK. (2013). Xeno-free production of human embryonic stem cells in stirred microcarrier systems using a novel animal/human-component-free medium. Tissue Eng Part C Methods, 19:146–155.
3.
FreitasER, SantosRL, LimaEC and GuilloLA. (2013). Feeder-free culture of human embryonic stem cell line BG01V/hOG using magnetic field-magnetic nanoparticles system. Biomed Pharmacother, 67:17–21.
4.
de Oliveira GeorgesJA, VerganiN, FonsecaSA, FragaAM, de MelloJC, AlbuquerqueMC, FujiharaLS and PereiraLV. (2014). Aberrant patterns of X chromosome inactivation in a new line of human embryonic stem cells established in physiological oxygen concentrations. Stem Cell Rev, 10:472–479.
5.
FernandesAM, MarinhoPA, SartoreRC, PaulsenBS, MarianteRM, CastilhoLR and RehenSK. (2009). Successful scale-up of human embryonic stem cell production in a stirred microcarrier culture system. Braz J Med Biol Res, 42:515–522.
6.
Alisson-SilvaF, de Carvalho RodriguesD, VairoL, AsensiKD, Vasconcelos-dos-SantosA, MantuanoNR, DiasWB, RondinelliE, GoldenbergRC, UrmenyiTP and TodeschiniAR. (2014). Evidences for the involvement of cell surface glycans in stem cell pluripotency and differentiation. Glycobiology, 24:458–468.
7.
StellingMP, LagesYM, TovarAM, MourãoPA and RehenSK. (2013). Matrix-bound heparan sulfate is essential for the growth and pluripotency of human embryonic stem cells. Glycobiology, 23:337–345.
8.
SuzukiDE, NakahataAM and OkamotoOK. (2014). Knockdown of E2F2 inhibits tumorigenicity, but preserves stemness of human embryonic stem cells. Stem Cells Dev, 23:1266–1274.
9.
Picanço-CastroV, Russo-CarbolanteE, ReisLC, FragaAM, de MagalhãesDA, OrellanaMD, PanepucciRA, PereiraLV and CovasDT. (2011). Pluripotent reprogramming of fibroblasts by lentiviral mediated insertion of SOX2, C-MYC, and TCL-1A. Stem Cells Dev, 20:169–180.
10.
PaulsenBaS, de Moraes MacielR, GalinaA, Souza da SilveiraM, dos Santos SouzaC, DrummondH, Nascimento PozzattoE, SilvaH, ChicaybamL, MassudaR, Setti-PerdigãoP, BonaminoM, Belmonte-de-AbreuPS, CastroNG, BrentaniH and RehenSK. (2012). Altered oxygen metabolism associated to neurogenesis of induced pluripotent stem cells derived from a schizophrenic patient. Cell Transplant, 21:1547–1559.
11.
PaulsenBaS, CardosoSC, StellingMP, CadilheDV and RehenSK. (2014). Valproate reverts zinc and potassium imbalance in schizophrenia-derived reprogrammed cells. Schizophr Res, 154:30–35.
12.
Mitne-NetoM, Machado-CostaM, MarchettoMC, BengtsonMH, JoazeiroCA, TsudaH, BellenHJ, SilvaHC, OliveiraAS, LazarM, MuotriAR and ZatzM. (2011). Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients. Hum Mol Genet, 20:3642–3652.
13.
Beltrão-BragaPC, PignatariGC, MaiorkaPC, OliveiraNA, LizierNF, WenceslauCV, MiglinoMA, MuotriAR and KerkisI. (2011). Feeder-free derivation of induced pluripotent stem cells from human immature dental pulp stem cells. Cell Transplant, 20:1707–1719.
14.
de Carvalho RodriguesD, AsensiKD, VairoL, Azevedo-PereiraRL, SilvaR, RondinelliE, GoldenbergRC, Campos de CarvalhoAC and UrményiTP. (2012). Human menstrual blood-derived mesenchymal cells as a cell source of rapid and efficient nuclear reprogramming. Cell Transplant, 21:2215–2224.
15.
AsensiKD, FortunatoRS, Dos SantosDS, PachecoTS, de RezendeDF, RodriguesDC, MesquitaFC, Kasai-BrunswickTH, de CarvalhoAC, CarvalhoDP, CarvalhoAB and GoldenbergRC. (2014). Reprogramming to a pluripotent state modifies mesenchymal stem cell resistance to oxidative stress. J Cell Mol Med, 18:824–831.
16.
Folha de São Paulo. Brasil terá primeiro teste clinico com células embrionarias. www1.folha.uol.com.br/ciencia/2013/08/1329467-brasil-tera-primeiro-teste-clinico-com-celulas-embrionarias.shtml
